Independent Insights, a Health Mart Podcast

Acne remains one of the most common dermatologic conditions encountered in pharmacy practice, making pharmacy teams an important resource for helping patients navigate treatment options and safe use. This course reviews recent updates in acne management, including new over-the-counter and prescription treatment options, practical considerations for therapy selection, and upcoming changes to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) program. You will be better prepared to support evidence-based acne care, appropriate therapy use, and safe dispensing of isotretinoin.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Jenna Mills, PharmD, BCPS
Associate Professor and Pharmacy Practice Department Vice Chair
University of Findlay

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in over-the-counter and prescription treatment options for acne. 
2. Explain key patient-use, safety, and regulatory considerations related to acne therapy, including changes to the iPLEDGE REMS program. 

Rachel Maynard and Jenna Mills have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-340-H01-P
Initial release date: 10/12/2026
Expiration date: 10/12/2029
Additional CPE details can be found here.

Testosterone therapy remains a frequently discussed and often controversial topic in patient care. This course reviews current perspectives on testosterone therapy, including potential benefits, safety considerations, monitoring recommendations, and areas of ongoing debate. You will be better prepared to interpret the evidence and support the safe and appropriate use of testosterone therapy in clinical practice.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Michael Nagy, PharmD
Clinical Pharmacy Practioner
Tomah VAMC

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe current indications, potential benefits, and safety considerations associated with testosterone therapy.
2. Identify evidence-based considerations for patient selection, monitoring, and safe use of testosterone therapy.

Rachel Maynard and Michael Nagy have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-339-H01-P 
Initial release date: 10/5/2026
Expiration date: 10/5/2029
Additional CPE details can be found here.

In this episode of Independent Insights, Britney Woods sits down with Dr. Amir Khan, owner of Hammer Lane Pharmacy, to explore the opportunities and realities of expanding into long-term care pharmacy services. Drawing from his experience growing from a traditional community pharmacy into hospice, assisted living, skilled nursing, and other long-term care settings, Dr. Khan shares practical insights on evaluating readiness, navigating operational and workflow considerations, building sustainable service models, and creating deeper connections with patients and care teams. Listeners will gain a candid perspective on the challenges, rewards, and opportunities with long-term care as a strategy for diversifying pharmacy services.

Host
Britney Woods, PharmD
Sr. Manager, Community Pharmacy
McKesson / Health Mart

Guests
Amir Khan, PharmD
Owner
Hammer Lane Pharmacy

Resources
Operations Handbook Content:

• Components of Patient-Centered Workflow
• Medication Synchronization Tasks

Health Marth Long Term Care Pharmacy Services Toolkit:
https://my.mckesson.com/newscenter/health-mart-ltc-toolkit
my.mckesson.com/solution-center/hm-ltc?cameFromSearch=true 

Tune into Episode 24: Automation That Works: How Independent Pharmacies Decide, Implement, and Thrive

Health Mart Pharmacies can access Health Mart University (HMU) for:

• Helpful CE courses and more on Supply Chain and Inventory Management Skills Training for Pharmacy Technicians, Technician Specialist: Inventory Management Training, Business Principles for Community Pharmacy Practice, Partnership for Success: Leveraging Value-Based Agreements for Community Pharmacy Growth, Key Benchmarks for Pharmacy Performance, Contracting 101: Understanding Third-Party Agreements, Compliance Risks, and Financial Impact
• Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes  

References
Community Pharmacists Fill Long-Term Care Gaps 

Pharmacies Offering some level of Long-Term Care Services: NCPA Releases 2023 Digest Report  

Pharmacies Considering Closing Their Business: NCPA: Independent Pharmacies Weigh Stocking Drugs Under Medicare Price Negotiation 

One in five people will be over age 65 by 2030: Demographic Turning Points for the United States: Population Projections for 2020 to 2060 

National Community Pharmacists Association 

The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

New medication approvals continue to expand treatment options across a wide range of disease states, making it essential for pharmacists to stay current with emerging therapies. This course reviews select medications approved within the past year, emphasizing their clinical applications, therapeutic roles, and important safety considerations. You will be better prepared to asse
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Joe Strain, Pharm.D
Professor Pharmacy Practice
South Dakota State University/Monument Health

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanisms of action, approved indications, and therapeutic roles of select newly approved medications.
2. Identify key safety, monitoring, and patient-use considerations associated with featured new therapies.

Rachel Maynard and Joe Strain have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-338-H01-P
Initial release date: 9/28/2026
Expiration date: 9/28/2029
Additional CPE details can be found here.

Questions about fertility and reproductive health are increasingly common in pharmacy practice, requiring pharmacists to provide accurate, evidence-based information across a range of patient concerns. This course uses a "Top Five FAQs" format to address common fertility questions, including the impact of obesity and weight-loss medications, fertility preservation strategies, advances in fertility treatment, and other timely reproductive health topics. You will be better prepared to answer patient questions and provide evidence-based counseling on fertility and reproductive health.

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education
CEimpact

GUEST
Alexis Ireland, PharmD
Doctor
University of Iowa Healthcare

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe factors that can influence fertility, including medications, medical conditions, and lifestyle considerations.
2. Explain evidence-based counseling considerations related to fertility preservation, fertility treatment options, and reproductive health.

Rachel Maynard and Alexis Ireland have no relevant financial relationships to disclose.

0.1 CEU/1.0 Hr
UAN: 0107-0000-26-324-H01-P
Initial release date: 9/21/2026
Expiration date: 9/21/2027
Additional CPE details can be found here.

GLP-1 receptor agonists remain an important and rapidly changing area of pharmacy practice, with new therapies, expanding indications, and evolving safety considerations shaping patient care. This course reviews recent developments in GLP-1 therapy, including newly approved medications, emerging evidence related to nutrition and oral health, and practical considerations for patient counseling and long-term management. You will be better prepared to evaluate new evidence, counsel patients on the safe and effective use of GLP-1 therapies, and incorporate recent updates into clinical practice.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Jennifer D. Goldman, PharmD, CDCES, BC-ADM, FCCP
Professor of Pharmacy Practice/Director of Cardiometabolic Services
Massachusetts College of Pharmacy-Boston, Well Life Medical 

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent developments in GLP-1 therapies, including newly approved medications.
2. Explain pharmacist-relevant considerations for counseling, safety monitoring, and long-term management of patients receiving GLP-1 therapies.

Jennifer Goldman is a member of the speakers bureau for Novo Nordisk, Amgen, Lilly, Xeris, CeQur, and Abbott Diabetes. All relevant financial relationships have been mitigated.  

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-323-H01-P
Initial release date: 9/14/2026
Expiration date: 9/14/2029
Additional CPE details can be found here.

Children are at increased risk for medication-related harm because of developmental differences, frequent off-label medication use, and unique adverse effect profiles. The Pediatric Pharmacy Association’s updated KIDs List identifies medications and excipients that should be avoided or used with caution in pediatric patients, providing pharmacists with an evidence-based tool to support safer prescribing and medication use. This course reviews key updates from the 2025 KIDs List and discusses practical strategies pharmacists can use to identify risks, recommend safer alternatives, and improve medication safety for pediatric patients.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Rachel Meyers, PharmD, BCPS, BCPPS
Clinical Professor / Pediatric Clinical Pharmacist
Ernest Mario School of Pharmacy, Rutgers University /
Cooperman Barnabas Medical Center

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe key medications and excipients included in the 2025 KIDs List and the pediatric safety concerns associated with their use.
2. Identify opportunities for pharmacists to apply KIDs List recommendations when evaluating medication therapy and counseling caregivers of pediatric patients.

Rachel Meyers is a Consultant for Wolters Kluwer. All relevant financial relationships have been mitigated.  

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-316-H01-P
Initial release date: 9/7/2026
Expiration date: 9/7/2029
Additional CPE details can be found here.

Cardiovascular-Kidney-Metabolic (CKM) syndrome recognizes the interconnected relationship among cardiovascular disease, kidney disease, obesity, diabetes, and other metabolic risk factors that contribute to long-term health outcomes. The first-ever CKM clinical practice guideline introduces a framework for risk assessment, staging, prevention, and management, emphasizing early identification and coordinated care across disease states. You will be better prepared to recognize CKM syndrome, understand its implications for patient care, and support evidence-based strategies to reduce cardiovascular, kidney, and metabolic risk.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Christine Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor, Pharmacy Practice and Clinical Pharmacist
Midwestern University

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the stages and key components of cardiovascular-kidney-metabolic syndrome.
2. Explain evidence-based strategies for identifying and managing patients at risk for CKM syndrome.

Christine Schumacher is a Speaker and Advisory Board Member for Abbott. All relevant financial relationships have been mitigated. 

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-315-H01-P
Initial release date: 8/31/2026
Expiration date: 8/31/2029
Additional CPE details can be found here.

Independent pharmacies play a vital role in expanding access to immunizations—during respiratory illness season and throughout the year. In this episode, host Britney Woods talks with Dr. Jessica Hung, clinical pharmacist and owner of Semmes Pharmacy, about building a sustainable vaccination program that supports patient care, strengthens pharmacy workflows, and creates year-round business opportunity. Dr. Hung shares practical strategies for preparing before vaccine season, engaging patients in meaningful conversations, using state immunization registries, managing inventory, empowering technicians, and overcoming common barriers to care. Listeners will walk away with actionable ideas to help strengthen immunization services and make a greater impact in their communities.

Host
Britney Woods, PharmD
Sr. Manager, Community Pharmacy
McKesson / Health Mart

Guests
Jessica Hung, PharmD
Semmes Pharmacy, Semmes, AL

Resources
For Health Mart pharmacies preparing for vaccination season, the Immunization Resource Kit offers convenient access to practical immunization resources and downloadable references available through my.mckesson.com.

Understanding the impact of your immunization program goes beyond the number of vaccines administered. For Health Mart Atlas members, Growing Revenue Opportunities or GRO, can help pharmacies identify vaccine administration revenue opportunities and gain insights into overall immunization program performance, helping connect clinical services with business outcomes. 

Are you a member of VOS yet? Vaccine Optimization Solution is an optional Health Mart Perk that gives eligible Health Mart members access to contracted discounts on select vaccines – there is no cost to access VOS. It’s an easy way to enhance purchasing flexibility and help maximize vaccine savings.

Patient access is a critical component of immunization services. For eligible Health Mart pharmacies seeking an immunization collaborative practice agreement option, Health Mart PERK$ offers access to an available CPA solution. This option can help pharmacies explore opportunities to support vaccine administration services and expand patient access to care.

Tune into Episode: 8 Vaccines in the Fast Lane: Operational Tips from a Pharmacy Owner 

Health Mart Pharmacies can access Health Mart University (HMU) for: 

• Helpful CE courses and more on Annual Immunization Update, Virtual Immunization Administration Training, Technician Specialist Vaccine Coordinator Course
  • 2026 Annual Immunization Update for Pharmacy Professionals (Pharmacists)
  • 2026 Annual Immunization Update for Pharmacy Professionals (Pharmacy Technicians)
• Health Mart pharmacists to claim their CE credit for weekly Gamechanger episodes 
  • GameChangers: Overcoming Barriers to Vaccine Hesitancy
  • GameChangers: Timely Updates in Pharmacy-Delivered Immunization Services   

References
Immunize.Org

Immunization Information Systems (IIS) to learn about connecting to your state’s Immunization Registry

The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.

The condition long known as polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its complex endocrine, metabolic, reproductive, and mental health effects. The name change highlights a growing recognition that this condition extends far beyond ovarian findings and requires a more comprehensive approach to diagnosis, treatment, and long-term risk management. You will be better prepared to understand the rationale behind the new terminology and support patients through evidence-based management of this multifaceted condition.
 

HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact

GUEST
Erin Raney, PharmD, BCPS
Professor
Midwestern University College of Pharmacy

 
Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!


CPE INFORMATION
 Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the rationale for the transition from polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS).
2. Explain the endocrine, metabolic, and reproductive features that influence the management of PMOS.

Rachel Maynard and [Speaker] have no relevant financial relationships to disclose.

0.075 CEU/0.75 Hr
UAN: 0107-0000-26-314-H01-P
Initial release date: 8/24/2026
Expiration date: 8/24/2029
Additional CPE details can be found here.